Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 7 de 7
Filtre
Ajouter des filtres








Gamme d'année
1.
Chinese Journal of Medical Instrumentation ; (6): 273-277, 2022.
Article Dans Chinois | WPRIM | ID: wpr-928903

Résumé

A high-precision human metabolic measurement system is designed. The system uses STM32F103 as the main control chip to acquire oxygen, carbon dioxide and flow signals to calculate four quantitative indicators: oxygen consumption(VO2), carbon dioxide production(VCO2), respiratory entropy(RQ) and resting energy metabolism(REE), and finally uses an upper computer to display the calculation results.In this paper, the signal acquisition circuit design was carried out for the oxygen sensor, carbon dioxide sensor and flow sensor, and the validity of the device was verified with the American machine MGCDiagnositcs using Bland-Altman analysis method, and the results showed that the four parameters of VO2,VCO2, RQ and REE of both devices fell in the agreement interval of more than 95%. The device thus provides accurate metabolic measurements and offers an effective tool for the field of general health and clinical nutrition support in China.


Sujets)
Humains , Calorimétrie indirecte , Dioxyde de carbone/métabolisme , Métabolisme énergétique , Oxygène , Consommation d'oxygène
2.
Acta Pharmaceutica Sinica ; (12): 1554-1563, 2019.
Article Dans Chinois | WPRIM | ID: wpr-780266

Résumé

The long-term use of antibiotics in clinical practice leads to bacterial variation and resistance. In addition, the excessive or improper use of antibiotics in medical and agricultural fields increases the occurrence of bacterial resistance. In 2017, the World Health Organization has for the first time released a list of 12 bacteria or bacterial families that pose the greatest threat to human health and for which new antibiotics are desperately needed, and three quarters of them are Gram-negative bacteria. Gram-negative bacteria has multi-layered cell wall that prevents many antibiotics from accessing their targets. Therefore, it is very difficult to develop drugs against Gram-negative bacteria, no new class of antibiotic has been approved for Gram-negative pathogens in over fifty years. Here, we summarized recent advances in the study of new antibacterial agents with different mechanisms of action against Gram-negative pathogens.

3.
Acta Pharmaceutica Sinica ; (12): 644-651, 2014.
Article Dans Anglais | WPRIM | ID: wpr-245033

Résumé

In recent studies some urea derivatives have been identified as potent anti-tuberculosis agents by targeting mycobacterial membrane protein large 3 (MmpL3). However, this compound series as exemplified by AU1235 exhibited poor in vitro pharmacokinetic profile. With AU1235 as the lead, we have identified a novel benzimidazole series as potential anti-tuberculosis agents by using scaffold hopping approach. Among these synthesized compounds, 2-aminobenzimidazole derivative 8b showed the potent anti-tuberculosis activity with the MIC value of 0.03 microg x mL(-1). This compound also showed improved metabolic stability compared to AU1235. Our investigation indicated that benzimidazole derivatives are the promising lead for further optimization as anti-tuberculosis agents.


Sujets)
Humains , Antituberculeux , Pharmacologie , Benzimidazoles , Chimie , Pharmacologie , Conception de médicament , Relation structure-activité , Tuberculose , Traitement médicamenteux
4.
Acta Pharmaceutica Sinica ; (12): 709-717, 2013.
Article Dans Anglais | WPRIM | ID: wpr-235606

Résumé

A novel series of benzyl urea analogues based on the structural modification of sorafenib were synthesized. Their in vitro antitumor activities against MX-1, HepG2, Ketr3 and HT-29 were evaluated using the standard MTT assay. While several target compounds showed inhibitory activity against multiple cancer cell lines, compound 9 was of particular interest, demonstrating IC50 values (5.69-13.6 micromol x L(-1)) comparable to those of sorafenib. Furthermore, compounds 20 and 23 showed more potent inhibitory activity against HT-29 and MX-1 when compared to sorafenib. In particular, compound 20 bearing the N-3-pyridyl moiety not only exhibited greater inhibitory activity against HT-29 cell line (IC50 3.82 micromol x L(-1)), but also had improved solubility at pH 7.2, is worthy of further investigation as a lead to identify novel antitumor agents.


Sujets)
Humains , Antinéoplasiques , Chimie , Pharmacologie , Lignée cellulaire tumorale , Prolifération cellulaire , Tests de criblage d'agents antitumoraux , Cellules HT29 , Concentration inhibitrice 50 , Structure moléculaire , Nicotinamide , Chimie , Pharmacologie , Phénylurées , Chimie , Pharmacologie , Solubilité , Relation structure-activité , Urée , Chimie , Pharmacologie
5.
Acta Pharmaceutica Sinica ; (12): 745-754, 2012.
Article Dans Anglais | WPRIM | ID: wpr-276249

Résumé

A series of novel riminophenazine derivatives bearing an alkyl substituent attached to N-5 and imino nitrogen at C-3 position of the phenazine ring were obtained through rational drug design, aiming to maintain high anti-tubercular activity, lower toxicity and reduce lipophilicity. All target compounds were prepared by utilizing simple and flexible synthetic route and evaluated against Mycobacterium tuberculosis H37Rv and screened for mammalian cytotoxicity. The results demonstrated that compounds with a cyclopropyl substituent at N-5 position were more active than the reference compound clofazimine. In particular, 2-(4-chloroanilino)-5-cyclopropyl-3-(4-methoxycyclohexyl) imino-3, 5-dihydrophenazine (25) was found to be the most potent compound with low cytotoxicity and lipophilicity. This compound could serve as a valuable lead molecule for further optimization.


Sujets)
Animaux , Antituberculeux , Chimie , Pharmacologie , Chlorocebus aethiops , Conception de médicament , Tests de sensibilité microbienne , Structure moléculaire , Mycobacterium tuberculosis , Phénazines , Chimie , Pharmacologie , Cellules Vero
6.
Acta Pharmaceutica Sinica ; (12): 1379-1384, 2010.
Article Dans Chinois | WPRIM | ID: wpr-353350

Résumé

To research the structure-activity relationship (SAR) of glycinamide-bearing compounds that used as inhibitors of dipeptidyl peptidase IV (DPP-IV), P32/98 and compound A were chosen as the leading compounds, heterocycles containing nitrogen atom were introduced to form amide, and different residues on a-position of carbonyl were designed. The nineteen designed compounds were synthesized by a simple route and were evaluated as inhibitors of DPP-IV. All of the structures were characterized by 1H NMR and HRMS. The preliminary SAR result was obtained.


Sujets)
Dipeptidyl peptidase 4 , Métabolisme , Inhibiteurs de la dipeptidyl-peptidase IV , Chimie , Pharmacologie , Conception de médicament , Glycine , Chimie , Spectroscopie par résonance magnétique , Méthodes , Structure moléculaire , Pipérazines , Chimie , Pharmacologie , Relation structure-activité
7.
China Biotechnology ; (12)2006.
Article Dans Chinois | WPRIM | ID: wpr-685570

Résumé

The optimization on liquid fermentation and purification of the fibrinolytic enzyme from Stenotrophomonas maltophilia(DR-929) was investigated.The results showed the best fermentation are amidulin 2.0%,soya flour 1.0%,yeast extract 0.5%,NaCl 1.0%,CaCl2 0.02%,MgSO4 0.05%,inoculum of 36 hours,fermental time 4d,initial pH 8.0 or 9.0,temperature 25℃,volume of media 30ml,volume of inoculum 5% or 6%.The purification process includes the following steps: removing cells by the centrifugation,25%~70% saturation ammonium sulfate precipitation,HIC with Phenyl FF(high sub),IEC with Q-Sepharose FF,gel filtration chromatography with Superdex 75.SDS-PAGE electrophoresis was used to examine the purification effect,and the results indicated that homogeneous strap in SDS-PAGE and has a molecular weight around 28.3kDa.The purification factor and activity recovery of the fibrinolytic enzyme are 271.5 and 24.5%,respectively.

SÉLECTION CITATIONS
Détails de la recherche